)
Deepak Korgaonkar boasts of an impressive 25-year experience on tracking and writing market stories based on extensive research and analysis of stocks/ sectors. He also specialises in reporting real-time stock market trends and impact stories. He holds a postgraduate degree from Mumbai University.
Deepak Korgaonkar boasts of an impressive 25-year experience on tracking and writing market stories based on extensive research and analysis of stocks/ sectors. He also specialises in reporting real-time stock market trends and impact stories. He holds a postgraduate degree from Mumbai University.
In the past month, Balrampur Chini Mills outperformed the market by surging 21 per cent, against a 0.5 per cent rise in the BSE Sensex.
Tamilnad Mercantile Bank, ESAF Small Finance Bank, Equitas Small Finance Bank and CSB Bank were up in the range of 2% to 5% on the BSE in an otherwise tepid market on Tuesday.
The trading volume at the Karur Vysya Bank counter jumped nearly 10-fold versus the average volume, with a combined 17.5 million shares changing hands on the NSE and BSE till 09:41 AM on Tuesday.
Pharma stocks: RPG Life, Thyrocare, Hester Biosciences, Rubicon Research, IOL Chemicals, Emcure and Suven Life from the BSE Healthcare index rallied between 4% and 8% on Monday.
In the recently concluded June 2026 quarter, domestic mutual funds reduced their stake in MTAR Technologies to 20.36 per cent from 23.49 per cent at the end of March 2026 quarter.
Share price of Gabriel India hit an all-time high of ₹1,453.60, surging 9% on the BSE in Monday's intra-day trade in an otherwise weak market.
Tatva Chintan Pharma: The stock price of the specialty chemicals hit a 52-week high of ₹1,714.10, and rallied 43% thus far in July.
HDFC Bank and Axis Bank were down 5 per cent each, while Yes Bank and Kotak Mahindra Bank from the Nifty Bank index were down 4 per cent each in intra-day deals on Monday.
At 01:59 PM on Friday, the Nifty Midcap 100 and Nifty Smallcap 100 indices were down 0.6 per cent each, as against 0.7 per cent rise in the Nifty 50 index.
However, despite recovery from lows, the Nifty IT index underperformed the market by falling 22 per cent, as against a 7.2 per cent decline in the Nifty 50 thus far in CY2026.
Thus far in the calendar year 2026, RIL underperformed the market by falling 16 per cent, as compared to 8.7 per cent decline in the BSE Sensex.
Analysts at ICICI Securities have a 'Buy' rating on BHEL stock with a fair value of ₹575 as they expect revenue and PAT to grow at a CAGR of 30.5 per cent and 90 per cent over FY26-FY28E.
UTI AMC, Nuvama Wealth Management, 360 ONE WAM, KFin Technologies, Angel One and MCX dropped 3 per cent each in intra-day trade on Thursday.
Unimech Aerospace stock hit a 52-week high at ₹1,308, and has bounced back 88 per cent from its 52-week low of ₹695.05 hit on March 30, 2026.
Thus far in the calendar year 2026, ABB India has outperformed the market by surging 53 per cent, as compared to 9 per cent decline in the BSE Sensex.
Biocon received approval from the European Medicines Agency (EMA) for a new drug product fill finish line for Semglee (insulin glargine) at its insulin manufacturing facility in Malaysia.
Share price of Emmvee Photovoltaic Power hit a new high of ₹371.45, surging 10% in Thursday's intra-day deals after reporting over 100% growth in Q1 net profit.
The Union Cabinet granted approvals to two key schemes: the Mobile Phone Manufacturing Scheme with an outlay of ₹62,500 crore, and ISM 2.0 with a budgeted outlay of ₹1.3 trillion.
According to the shareholding data, ace investor Mukul Agrawal held 1.45 equity stake in Hind Rectifiers as of March 2026.
Looking beyond the Q1, analysts expect domestic cement demand to grow at a healthy 6-8 per cent CAGR over FY27-FY29, driven by sustained public infra investments and housing demand.